Skip to main content
Signal8

Cell Source, Inc. (CLCS)

Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Cell Source, Inc. logo

Cell Source, Inc.

OTC:CLCSHealthcare
-19.61%$0.4260
Mkt Cap$28.94M
Float37.26M
O/S67.95M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$4.64M
Total Assets$464K
Free Cash Flow-$2.73M
Debt & Equity
Total Debt$12.98M
Total Equity-$22.46M
Preferred Stock$297
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in CLCS's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$464K
Liabilities$22.93M
Accounts Receivable$0
Accounts Payable$1.21M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
YoY Growth--------------
Cost of Revenue$0$0$0$0$0$0$0$0$407$0$860$455$0$0
Gross Profit$0$0$0$0$0$0$0$0-$407$0-$860-$455$0$0
Gross Margin--------------
Research and Development$1.18M$1.9M$1.58M$2M$1.32M$999K$2.63M$725K$1.48M$1.37M$1.22M$1.82M$1K$1K
Selling, General, and Administrative$1.55M$1.95M$2.6M$2.18M$2.69M$2.64M$1.18M$1.28M$816K$952K$1.1M$2.24M$26K$447
Other$0$0$142K$0$1K$446$0$0$0$0$0$0$0$0
Total Operating Expenses$2.73M$3.85M$4.33M$4.17M$4.02M$3.64M$3.81M$2.01M$2.29M$2.32M$2.32M$4.05M$26K$2K
Operating Income (EBIT)-$2.73M-$3.85M-$4.33M-$4.17M-$4.02M-$3.64M-$3.81M-$2.01M-$2.29M-$2.32M-$2.32M-$4.05M-$26K-$2K
Operating Margin--------------
Interest Expense$2.03M$1.17M$1.05M$992K$1.36M$937K$308K$479K$227K$281K$36K$0$0$0
Interest Income$0$0$0$992$1K$937$0$0$0$0$0$0$0$9
Other Income (Expense)-$1.91M-$923K-$996K-$992K-$1.45M-$922K-$670K-$111K-$790K$1.35M-$184K-$3K$0$5
Income Before Tax (EBT)-$4.64M-$4.77M-$5.32M-$5.17M-$5.47M-$4.56M-$4.47M-$2.12M-$3.08M-$968K-$2.5M-$4.06M-$26K-$2K
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0$0$5
Net Income-$4.64M-$4.77M-$5.32M-$5.17M-$5.47M-$4.56M-$4.47M-$2.12M-$3.08M-$968K-$2.5M-$4.06M-$26K-$2K
Net Income Margin--------------
Supplementary Data
EPS-0.10-0.15-0.17-0.18-0.19-0.19-0.18-0.08-0.12-0.04-0.10-0.18-0.00-0.14
Diluted EPS-0.10-0.15-0.17-0.18-0.19-0.19-0.18-0.08-0.12-0.04-0.10-0.18-0.00-0.14
Weighted Average OS54.36M41.87M37.79M34.84M28.12M29.10M28.33M27.55M26.77M26.19M25.72M22.19M13.17M12,067
EBITDA-$2.73M-$3.6M-$3.89M$333-$93K$301.25B-$460K-$2.01M-$2.29M-$3.56M-$2.32M-$4.05M$333K-$1
EBITDA Margin--------------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$462K$75K$22K$223K$93K$245K$28K$19K$371K$4K$7K$19K$19K$22K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$462K$75K$22K$223K$93K$245K$28K$19K$371K$4K$7K$19K$19K$22K
Accounts Receivable$0$50K$0$0$0$0$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$2K$1K$12K$23K$17K$30K$30K$8K$36K$70K$135K$26K$63K$0
Total Current Assets$464K$287K$195K$410K$314K$452K$115K$66K$532K$211K$338K$121K$19K$22K
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0$0$0$0$0$407$1K$2K$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$172.97M$0$0$4K$86.88M$0$0$0$28K$0$0$0
Total Long-Term Assets$0$0$172.97M$0$0$4K$86.88M$0$0$407$30K$2K$0$0
Other Assets$0$0-$172.97B$0$0-$4K-$86.88B$0$0$0$0$0$0$0
Total Assets$464K$287K$195K$410K$314K$452K$115K$66K$532K$211K$368K$123K$19K$22K
Liabilities
Current Liabilities
Accounts Payable$1.21M$1.89M$1.47M$680K$223K$193K$135K$278K$202K$219K$120K$415$0$0
Short-Term Debt$12.98M$10.07M$9.25M$7.9M$6.47M$4.81M$2.55M$2.67M$2.32M$3.09M$1.07M$100K$0$0
Current Income Tax Payable$0$0$133K$128K$125K$122K$118K$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$3.42M$0$2.77M$100B$1.94M$1.97M$450B-$285K$0$0
Other Current Liabilities$7.51M$6.05M$4.12M$240K-$573K$321K-$2.17M$1.54M$2.12M$1.48M$4.04M$2.32M-$993K$0
Total Current Liabilities$22.93M$19.08M$15.81M$13.04M$10.14M$8.4M$5.71M$4.99M$5.09M$6.45M$6.05M$3.91M$7K$5K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$145K$0$0$0$44K$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$33K$0$0$0
Total Long-Term Liabilities$0$0$0$0$6.69M$0$145K$2.95M$2.52M$3.31M$76K$100K$0$0
Other Liabilities$0$0$0$0-$6.69M-$5M$0-$2.95M-$2.52M-$3.31M$0-$100K$0$0
Total Liabilities$22.93M$19.08M$15.81M$13.04M$10.14M$8.4M$5.86M$4.99M$5.09M$6.45M$6.13M$3.91M$7K$5K
Stockholders' Equity
Preferred Stock$297$2K$2K$2K$2K$1K$1K$860$644$0$0$0$0$0
Common Stock$68K$45K$40K$36K$34K$33K$27K$26K$25K$25K$24K$24K$6K$6K
Retained Earnings-$50.82M-$46.44M-$41.67M-$36.35M-$31.18M-$25.71M-$21.15M-$16.67M-$14.55M-$11.47M-$10.5M-$8M-$31K-$5K
Comprehensive Income & Other$0$0$0$0$0$0$0-$860-$644$0$0$0$0$0
Other Stockholders' Equity$28.29M$27.6M$26.02M$23.68M$21.32M$17.73M$15.38M$11.72M$9.97M$5.2M$4.72M$4.19M$36K$17K
Total Equity-$22.46M-$18.8M-$15.61M-$12.63M-$9.83M-$7.95M-$5.74M-$4.92M-$4.56M-$6.24M-$5.76M-$3.78M$11K$17K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$464K$287K$195K$410K$314K$452K$115K$66K$532K$211K$368K$123K$19K$22K
Supplementary Data
Total Debt$12.98M$10.07M$9.25M$7.9M$6.47M$4.81M$2.6M$2.67M$2.32M$3.09M$1.27M$100K$0$0
Net Debt$12.52M$9.99M$9.23M$7.68M$6.38M$4.56M$2.57M$2.65M$1.95M$3.08M$1.26M$81K-$19K-$22K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$4.64M-$4.77M-$5.32M-$5.17M-$5.47M-$4.56M-$4.48M-$2.12M-$3.08M-$968K-$2.5M-$4.06M-$26K-$2K
Depreciation & Amortization$0$0$381K$4.18M$4.02M$301.25B$3.81M$407$407$860$860$455$358K$2K
Deferred Income Tax$0$0$0-$285.3B-$731.5B-$301.25B-$14.97B-$209.66B-$590K-$2.87M-$344K-$944K$0$0
Stock-Based Compensation$0$288K$445K$78K$419K$792K$844K-$19K$45K$115K$136K$944K$0$0
Changes in Working Capital:
  Accounts Receivable$50K$0$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable-$676K$422K$787K$457K$30K$58K-$142K$76K-$17K$99K$323.85B$28.48B$0$0
  Other Working Capital$1.79M$1.34M$1.43M$1.11M$671K$366K$712K$216K$155K$856K-$323.85B-$28.48B$0$0
Total Working Capital Change$1.16M$1.76M$2.22M$1.56M$701K$423K$570K$292K$138K$955K$219K-$10K$2K$0
Other Non-Cash Items$742K$326K-$71K$285.3B$731.5B$571K$14.97B$209.66B$1.2M$1.27M$492K$947K-$358K-$2K
Net Cash from Operating-$2.73M-$2.68M-$2.35M-$3.14M-$3.38M-$2.77M-$2.59M-$2M-$2.29M-$1.49M-$2M-$3.12M-$23K-$2K
Investing Activities
Capital Expenditures$0$0$0$0$0$0$0$0$0$0$0-$3K$0$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0$0$0$0$0-$2.58B$0$0
Net Cash from Investing$0$0$0$0$0$0$0$0$0$0$0-$3K$0$0
Financing Activities
Debt Repaid---$920K-$3.3M-$3.58M-$2.3M-$715K-$500K-$360K-$1.45M----
Common Stock Issuance$485K$641K$800K$0$0$730K$1.8T$1.05T$2.3T$0$71.4B$3.01M$551K$0
Common Stock Repurchases$0$0$0$0$0$0-$1.05T$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0-$877.74B-$741.98B-$451.28B$0$0$0$0$0$0
Other Financing Activities$12K$111K-$279K-$28K$944K$877.74B$741.98B$451.28B$0$38K$411K$3.01M$0$1K
Net Cash from Financing$3.12M$2.74M$2.15M$3.27M$3.23M$2.99M$2.6M$1.65M$2.66M$1.49M$1.99M$3.11M$20K$1K
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$387K$52K-$200K$130K-$152K$217K$9K-$352K$367K-$3K-$13K-$9K-$3K-$425
Supplementary Data
Operating Cash Flow-$2.73M-$2.68M-$2.35M-$3.14M-$3.38M-$2.77M-$2.59M-$2M-$2.29M-$1.49M-$2M-$3.12M-$23K-$2K
Capital Expenditure$4$0$0-$4$0$0$0$0$0$0$0-$3K$0$0
Free Cash Flow-$2.73M-$2.68M-$2.35M-$3.14M-$3.38M-$2.77M-$2.59M-$2M-$2.29M-$1.49M-$2M-$3.12M-$23K-$2K
Cash at Beginning$75K$22K$223K$93K$245K$28K$19K$371K$4K$7K$19K$29K$22K$587
Cash at End$462K$75K$22K$223K$93K$245K$28K$19K$371K$4K$7K$19K$19K$161